Catriona Jamieson

Dr. Catriona Jamieson is a leading physician-scientist who discovered missplicing, RNA hyper-editing,
and splice isoform switching as mechanisms governing human cancer stem cell maintenance in
selective niches. Dr. Jamieson has extensive experience in development of stem cell models and
therapies, including small molecule drugs, as well as commercialization of these technologies. At the
Sanford Stem Cell Institute, Dr. Jamieson and her team are examining the links between aging and
systemic inflammation-related microenvironmental and macroenvironmental stressors that promote
pre-cancer initiation and malignant transformation of human hematopoietic stem and progenitor
cells. As part of the NASA Integrated Space Stem Cell Orbital Research (ISSCOR) program, Dr. Jamieson
has led the engineering of human hematopoietic stem cell and tumor organoid nanobioreactors and
development of multi-omic and functional analytical methods to determine stem cell fitness before,
during and after space flight. Dr. Jamieson received the 2017 MPN Hero’s Award, the Moores Cancer
Center Rell Sunn Award in 2020, and the Top Doctor for the 10th consecutive year by Castle Connolly
in 2021. She has served as a keynote speaker on stem cells and pre-cancer and was awarded the UC
San Diego Academic Senate Distinguished Research Award in 2023 and will be awarded the Luminary
Award, Precision Medicine World Conference, in 2024. Her visionary leadership resulted in the single
largest gift in the history of UC San Diego, for $150 million from T. Denny Sanford, resulting in the
creation of the Sanford Stem Cell Institute.